(Q34653402)

12 December 2020

The challenge of long-acting beta-adrenoceptor agonists

1 reference

12 December 2020

Subsensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects

1 reference

12 December 2020

Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine

1 reference

12 December 2020

Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis

1 reference

12 December 2020

Action of corticosteroids on beta-adrenergic receptors. Clinical aspects.

1 reference

12 December 2020

Approaches to a long-acting, selective beta 2-adrenoceptor stimulant.

1 reference

12 December 2020

The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta- adrenoceptor agonists

1 reference

12 December 2020

Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol.

1 reference

12 December 2020

A scale for assessing quality of life in adult asthma sufferers.

1 reference

12 December 2020

Nocturnal asthma: a study in general practice

1 reference

12 December 2020

β2-agonists in asthma

1 reference

12 December 2020

Asthma specific quality of life scale in a study of salmeterol hydroxynaphthoate

1 reference

12 December 2020

Exacerbations of asthma in patients on salmeterol

1 reference

12 December 2020

Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo

1 reference

12 December 2020

Salbutamol in the 1980s. A reappraisal of its clinical efficacy

1 reference

12 December 2020

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

12 December 2020

1 reference

12 December 2020

A comparison of slow-release salbutamol with slow-release aminophylline in nocturnal asthma

1 reference

12 December 2020

Basic pharmacology of new long-acting sympathomimetics

1 reference

12 December 2020

Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist

1 reference

12 December 2020

One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists

1 reference

12 December 2020

Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease

1 reference

12 December 2020

Twice daily slow-release theophylline vs placebo for ‘morning-dipping’ in asthma

1 reference

12 December 2020

Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung

1 reference

12 December 2020

Slow-release oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels

1 reference

12 December 2020

The pharmacology of salmeterol

1 reference

12 December 2020

A Single-dose Comparison of Inhaled Albuterol and Two Formulations of Salmeterol on Airway Reactivity in Asthmatic Subjects

1 reference

12 December 2020

Asthma exacerbations in patients taking regular salmeterol, or salbutamol for symptoms

1 reference

12 December 2020

Duration of Protection by Inhaled Salmeterol in Exercise-induced Asthma

1 reference

12 December 2020

Protection against allergen-induced asthma by salmeterol

1 reference

12 December 2020

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients

1 reference

12 December 2020